Mylan Launches Generic Felbatol
Felbamate Tablets are indicated for monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy. They are also indicated as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children.
Felbamate, a carbamate anticonvulsant, exhibits weak inhibitory effects on GABA-receptor binding and benzodiazepine receptor binding. It is devoid of activity at the MK-801 receptor binding site of the NMDA receptor-ionophore complex. The exact mechanism by which felbamate exerts its anticonvulsant activity is unknown.
Felbamate tablets are available in 400mg and 600mg strengths.
For more information call (800) RX-MYLAN or visit Mylan.com.